BLCM - Bellicum Pharma Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 XEL (0%) WMT (0%) VUZI (0%) V (0%) TLRY (0%) SQQQ (0%) SEDG (0%) PCAR (0%) LC (5.78%) JPM (-0.41%) INMD (0%) F (0%) CAKE (0%) BTCUSD (%) AMD (0%)

BLCM - Bellicum Pharmaceuti...

$3.09 0[0%]

15 mins delayed data

People also watch : ALDX | TTOO

+Watchlist

5 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$3.09	Open
Volume		Market Cap	93.86M
Yield		Last Dividend

Day

52 Week

Bellicum Pharmaceuticals Reports Inducem...	07/26/21
HOUSTON, July 26, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunothe...

Knee Bursitis Treatment Market 2021 SWOT...	07/25/21
This report studies the Knee Bursitis Treatment Market with many aspects of the industry such as market size, market status, market trends and forecas...

Bone Marrow Transplant Rejection Treatme...	07/24/21
This report studies the Bone Marrow Transplant Rejection Treatment Market with many aspects of the industry such as market size, market status, market...

Rhabdomyosarcoma Drug Market 2021 SWOT A...	07/24/21
This report studies the Rhabdomyosarcoma Drug Market with many aspects of the industry such as market size, market status, market trends and forecast....

Bellicum Enters License Agreement with U...	06/28/21
HOUSTON, June 28, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunothe...

Should I Avoid Bellicum Pharmaceuticals ...	06/13/21
No summary available.

Invectys nominates Rosemary Williams, CP...	06/01/21
Houston, TX, USA, June 01, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the developme...

Bellicum Pharmaceuticals EPS beats by $0...	05/17/21
No summary available.

Bellicum Pharmaceuticals: Q1 Earnings Sn...	05/17/21
HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Monday reported a first-quarter loss of $11.3 million, after reporting a profit in the same per...

Bellicum Reports First Quarter 2021 Fina...	05/16/21
Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financi...

Bellicum Pharmaceuticals: Narrowing The ...	05/13/21
No summary available.

Bellicum Pharmaceuticals Inc Shares Clos...	03/08/21
Bellicum Pharmaceuticals Inc shares closed today 10.0% higher than it did at the end of yesterday. The stock is currently up 4.5% year-to-date, down ...

Bellicum Pharmaceuticals Inc Shares Clos...	02/26/21
Bellicum Pharmaceuticals Inc shares closed this week 22.9% lower than it did at the end of last week. The stock is currently up 23.8% year-to-date, d...

Bellicum Pharmaceuticals Inc Shares Clos...	02/12/21
Bellicum Pharmaceuticals Inc shares closed this week 47.9% higher than it did at the end of last week. The stock is currently up 88.1% year-to-date, ...

Bellicum Pharmaceuticals Inc Shares Clos...	01/29/21
Bellicum Pharmaceuticals Inc shares closed today 21.1% higher than it did at the end of yesterday. The stock is currently up 31.7% year-to-date, down...

Bellicum Pharmaceuticals Inc Shares Clos...	01/28/21
Bellicum Pharmaceuticals Inc shares closed today 21.1% higher than it did at the end of yesterday. The stock is currently up 8.8% year-to-date, down ...

Bellicum Pharmaceuticals Inc Shares Clos...	01/26/21
Bellicum Pharmaceuticals Inc shares closed today 12.8% lower than it did at the end of yesterday. The stock is currently up 9.9% year-to-date, down 7...

Bellicum Pharmaceuticals Inc Shares Clos...	01/19/21
Bellicum Pharmaceuticals Inc shares closed today 18.1% higher than it did at the end of yesterday. The stock is currently up 9.3% year-to-date, down ...

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $BLCM

Service Name	Trader	% Success
Lewis Aung's long pick	Kyaw Aung	70.00 %	Subscribe
Mojo Day Trading	ProTrader Mike	46.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.